
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles from Medical Marketing and Media Media News</title>
        <link>http://www.mmm-online.com</link>
        <description>Latest articles from Medical Marketing and Media Media News</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle>Media News</itunes:subtitle>
        <itunes:summary>The latest media news from the healthcare marketing and communications sector</itunes:summary>
        <itunes:owner>
            <itunes:name>Media News</itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Media Choice</title>
          <description></description>
          <link>http://www.mmm-online.com/media-choice/article/215053/</link>
          <pubDate>Tue, 01 Nov 2011 04:00:00 GMT</pubDate>
          <itunes:summary></itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>WSJ: NEJM spiked drug company conflicts broadside</title>
          <description>The New England Journal of Medicine pulled an article slamming the National Kidney Foundation for its reliance on drug company donations, the Wall Street Journal reported.</description>
          <link>http://www.mmm-online.com/wsj-nejm-spiked-drug-company-conflicts-broadside/article/23762/</link>
          <pubDate>Wed, 27 Dec 2006 09:16:00 GMT</pubDate>
          <itunes:summary>The New England Journal of Medicine pulled an article slamming the National Kidney Foundation for its reliance on drug company donations, the Wall Street Journal reported.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news from the 11/14/06 News Brief</title>
          <description>Genentech has agreed to acquire its Xolair co-marketer, the Houston-basedbiotech firm Tanox, in a deal worth $919 million.</description>
          <link>http://www.mmm-online.com/company-news-from-the-111406-news-brief/article/23660/</link>
          <pubDate>Tue, 14 Nov 2006 23:58:00 GMT</pubDate>
          <itunes:summary>Genentech has agreed to acquire its Xolair co-marketer, the Houston-basedbiotech firm Tanox, in a deal worth $919 million.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Duramed starts to pitch OTC Plan B</title>
          <description>OTC Plan B is launching with detailing and professional ads, but the campaign will include a nod to consumers, too.</description>
          <link>http://www.mmm-online.com/duramed-starts-to-pitch-otc-plan-b/article/23656/</link>
          <pubDate>Tue, 07 Nov 2006 23:59:00 GMT</pubDate>
          <itunes:summary>OTC Plan B is launching with detailing and professional ads, but the campaign will include a nod to consumers, too.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>AARP, PhRMA launch campaigns on opposite sides of reimportation debate</title>
          <description>The AARP has launched a $500,000 ad campaign in 14 states pushing for Senate action on legislation to let consumers buy US-made Rx drugs from Canada.</description>
          <link>http://www.mmm-online.com/aarp-phrma-launch-campaigns-on-opposite-sides-of-reimportation-debate/article/23554/</link>
          <pubDate>Tue, 19 Sep 2006 20:14:00 GMT</pubDate>
          <itunes:summary>The AARP has launched a $500,000 ad campaign in 14 states pushing for Senate action on legislation to let consumers buy US-made Rx drugs from Canada.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>WebMD acquires Medsite in $41 million deal</title>
          <description>WebMD Health has entered into a deal to acquire the interactive medical education, promotion and physician recruitment businesses of Medsite.</description>
          <link>http://www.mmm-online.com/webmd-acquires-medsite-in-41-million-deal/article/23455/</link>
          <pubDate>Tue, 25 Jul 2006 19:09:00 GMT</pubDate>
          <itunes:summary>WebMD Health has entered into a deal to acquire the interactive medical education, promotion and physician recruitment businesses of Medsite.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>JAMA editor says she was misled again</title>
          <description>Just days after an announced crackdown on researchers who fail to disclose their ties to drug makers, the editor of the Journal of the American Medical Association (JAMA) said she has been misled again, this time by the authors of a study linking severe migraines to heart attacks in women.</description>
          <link>http://www.mmm-online.com/jama-editor-says-she-was-misled-again/article/23451/</link>
          <pubDate>Tue, 25 Jul 2006 19:02:00 GMT</pubDate>
          <itunes:summary>Just days after an announced crackdown on researchers who fail to disclose their ties to drug makers, the editor of the Journal of the American Medical Association (JAMA) said she has been misled again, this time by the authors of a study linking severe migraines to heart attacks in women.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Sunrise Senior Living and Haymarket launch Sunrise Magazine for caregivers</title>
          <description>Sunrise Senior Living, the nation’s largest senior care franchise, has hired Haymarket Media to publish Sunrise Magazine, a title aimed at caregivers.</description>
          <link>http://www.mmm-online.com/sunrise-senior-living-and-haymarket-launch-sunrise-magazine-for-caregivers/article/23274/</link>
          <pubDate>Fri, 07 Apr 2006 19:30:00 GMT</pubDate>
          <itunes:summary>Sunrise Senior Living, the nation’s largest senior care franchise, has hired Haymarket Media to publish Sunrise Magazine, a title aimed at caregivers.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pfizer retracts premature Exubera approval statement</title>
          <description>Pfizer retracted a remark made by its chief executive this morning that Exubera was approved in the US.</description>
          <link>http://www.mmm-online.com/pfizer-retracts-premature-exubera-approval-statement/article/23159/</link>
          <pubDate>Fri, 27 Jan 2006 22:07:00 GMT</pubDate>
          <itunes:summary>Pfizer retracted a remark made by its chief executive this morning that Exubera was approved in the US.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Judge rules Merck lawyers can question NEJM editor </title>
          <description>The federal judge overseeing Vioxx litigation ruled this week that Merck would be allowed to depose the executive editor of the New England Journal of Medicine (NEJM), according to a report in The Wall Street Journal (WSJ) this week.</description>
          <link>http://www.mmm-online.com/judge-rules-merck-lawyers-can-question-nejm-editor/article/23148/</link>
          <pubDate>Fri, 20 Jan 2006 21:33:00 GMT</pubDate>
          <itunes:summary>The federal judge overseeing Vioxx litigation ruled this week that Merck would be allowed to depose the executive editor of the New England Journal of Medicine (NEJM), according to a report in The Wall Street Journal (WSJ) this week.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Tamiflu radio ads belie global shortages: WSJ</title>
          <description>Roche has been running radio spots in the U.S. for its antiviral drug Tamiflu, even as other countries are plagued by shortages, The Wall Street Journal reports.</description>
          <link>http://www.mmm-online.com/tamiflu-radio-ads-belie-global-shortages-wsj/article/23136/</link>
          <pubDate>Mon, 16 Jan 2006 21:08:00 GMT</pubDate>
          <itunes:summary>Roche has been running radio spots in the U.S. for its antiviral drug Tamiflu, even as other countries are plagued by shortages, The Wall Street Journal reports.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>NEJM articles fuel debate over sponsored research</title>
          <description>Conflicting articles within the pages of the New England Journal of Medicine (NEJM) have once again spawned debate over the validity of drug-company sponsored research appearing in medical journals.</description>
          <link>http://www.mmm-online.com/nejm-articles-fuel-debate-over-sponsored-research/article/22873/</link>
          <pubDate>Thu, 04 Aug 2005 18:08:23 GMT</pubDate>
          <itunes:summary>Conflicting articles within the pages of the New England Journal of Medicine (NEJM) have once again spawned debate over the validity of drug-company sponsored research appearing in medical journals.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Hypertension society splits with journal in CME dispute</title>
          <description>The American Society of Hypertension (ASH) has ended its 16-year relationship with the American Journal of Hypertension (AJH) in a dispute over the control and credibility of the society’s continuing medical education symposia.</description>
          <link>http://www.mmm-online.com/hypertension-society-splits-with-journal-in-cme-dispute/article/22867/</link>
          <pubDate>Mon, 01 Aug 2005 18:04:20 GMT</pubDate>
          <itunes:summary>The American Society of Hypertension (ASH) has ended its 16-year relationship with the American Journal of Hypertension (AJH) in a dispute over the control and credibility of the society’s continuing medical education symposia.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Media People News from the 7/22 News Brief</title>
          <description>The American Medical Association has appointed Tim Melroy to senior account manager for Archives of Ophthalmology, Archives of Otolaryngology, Archives of Pediatrics, Adolescent Medicine, and Archives of Facial Plastic Surgery. Melroy worked at M.J. Mrvica Associates as an account manager.</description>
          <link>http://www.mmm-online.com/media-people-news-from-the-722-news-brief/article/22852/</link>
          <pubDate>Fri, 22 Jul 2005 21:13:11 GMT</pubDate>
          <itunes:summary>The American Medical Association has appointed Tim Melroy to senior account manager for Archives of Ophthalmology, Archives of Otolaryngology, Archives of Pediatrics, Adolescent Medicine, and Archives of Facial Plastic Surgery. Melroy worked at M.J. Mrvica Associates as an account manager.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Study finds nearly one-third of journal research contradicted</title>
          <description>Nearly one-third of the results of major studies published in three of the top medical journals between 1990 and 2003 have been refuted, according to a report in Wednesday’s Journal of the American Medical Association (JAMA).</description>
          <link>http://www.mmm-online.com/study-finds-nearly-one-third-of-journal-research-contradicted/article/22830/</link>
          <pubDate>Wed, 13 Jul 2005 18:06:02 GMT</pubDate>
          <itunes:summary>Nearly one-third of the results of major studies published in three of the top medical journals between 1990 and 2003 have been refuted, according to a report in Wednesday’s Journal of the American Medical Association (JAMA).</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Advanstar for sale</title>
          <description>Advanstar, the largest commercial medical publisher in the U.S., is up for sale.</description>
          <link>http://www.mmm-online.com/advanstar-for-sale/article/22817/</link>
          <pubDate>Thu, 07 Jul 2005 23:08:44 GMT</pubDate>
          <itunes:summary>Advanstar, the largest commercial medical publisher in the U.S., is up for sale.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Advanstar&apos;s Callanan out amid talk of sale</title>
          <description>Advanstar’s head of healthcare publishing has left the company, as talk of a sale percolates through the business press.</description>
          <link>http://www.mmm-online.com/advanstars-callanan-out-amid-talk-of-sale/article/22814/</link>
          <pubDate>Wed, 06 Jul 2005 18:47:26 GMT</pubDate>
          <itunes:summary>Advanstar’s head of healthcare publishing has left the company, as talk of a sale percolates through the business press.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>AMA rebranding with $20 million campaign</title>
          <description>The American Medical Association is rebranding with a nearly $20 million advertising and outreach campaign aimed at shoring up membership and leveraging the group’s brand equity with patients to advance its political agenda.</description>
          <link>http://www.mmm-online.com/ama-rebranding-with-20-million-campaign/article/22774/</link>
          <pubDate>Thu, 16 Jun 2005 16:26:56 GMT</pubDate>
          <itunes:summary>The American Medical Association is rebranding with a nearly $20 million advertising and outreach campaign aimed at shoring up membership and leveraging the group’s brand equity with patients to advance its political agenda.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Medical schools split over drug firm role in research</title>
          <description>U.S. medical schools are willing to give pharma companies considerable control over study results of new drugs and treatments, according to an article appearing in yesterday’s New England Journal of Medicine (NEJM).</description>
          <link>http://www.mmm-online.com/medical-schools-split-over-drug-firm-role-in-research/article/22742/</link>
          <pubDate>Thu, 26 May 2005 17:15:10 GMT</pubDate>
          <itunes:summary>U.S. medical schools are willing to give pharma companies considerable control over study results of new drugs and treatments, according to an article appearing in yesterday’s New England Journal of Medicine (NEJM).</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>New England Journal of Medicine editor: Pharmas don’t disclose enough trial data</title>
          <description>Pfizer, GlaxoSmithKline and Merck are “making a mockery” of efforts to create greater transparency in drug clinical trials, the top editor at the New England Journal of Medicine (NEJM) said in a published report today</description>
          <link>http://www.mmm-online.com/new-england-journal-of-medicine-editor-pharmas-dont-disclose-enough-trial-data/article/22738/</link>
          <pubDate>Tue, 24 May 2005 17:33:00 GMT</pubDate>
          <itunes:summary>Pfizer, GlaxoSmithKline and Merck are “making a mockery” of efforts to create greater transparency in drug clinical trials, the top editor at the New England Journal of Medicine (NEJM) said in a published report today</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  